- idUS
- Listar por autor
Listar por autor "Arance, Ana M."
Mostrando ítems 1-1 de 1
-
Artículo
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
Larkin, James; Weber, Jeffrey; Del Vecchio, Michele; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cruz Merino, Luis de la; Mandalá, Mario (Elsevier Science Ltd, 2022)Abstract Purpose: Nivolumab was approved as adjuvant therapy for melanoma based on data from CheckMate 238, which enrolled ...